Señales en vivo de BML.WA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 jul 2023 @ 11:00):

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A., a biotechnology company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland...

Stats
Volumen de hoy	300 036
Volumen promedio	209 727
Capitalización de mercado	407.51M
EPS	PLN0.0106 ( 2023-05-26 )
Last Dividend	PLN0 ( N/A )
Next Dividend	PLN0 ( N/A )
P/E	52.73
ATR14	PLN0.192 (3.58%)

Volumen Correlación

Largo: 0.39 (neutral)

Corto: 0.90 (strong)

Signal:(42.076) Same movement expected

BIOMED-LUBLIN Wytwórnia Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BIOMED-LUBLIN Wytwórnia Correlación - Moneda/Commodity

-0.35
( neutral )

-0.49
( neutral )

-0.48
( neutral )

-0.52
( weak negative )

0.03
( neutral )

BIOMED-LUBLIN Wytwórnia Finanzas

Annual	2022
Ingresos:	PLN50.38M
Beneficio Bruto:	PLN27.93M (55.44 %)
EPS:	PLN0.0900

FY	2022
Ingresos:	PLN50.38M
Beneficio Bruto:	PLN27.93M (55.44 %)
EPS:	PLN0.0900

FY	2021
Ingresos:	PLN41.15M
Beneficio Bruto:	PLN22.67M (55.08 %)
EPS:	PLN0.0700

FY	2020
Ingresos:	PLN40.16M
Beneficio Bruto:	PLN20.57M (51.21 %)
EPS:	PLN0.0700

Financial Reports:

No articles found.

BIOMED-LUBLIN Wytwórnia

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A., a biotechnology company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50, a product used in treating superficial (non-muscle invasive) bladder tumour; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; BioTrombina 400, a medication for topical control of severe bleeding; and Anti-Tuberculosis Vaccine BCG 10, a medication used in tuberculosis prevention. It also offers medical products comprising Ram blood for laboratory use; stonebrink medium for biovine Mycobacterium tuberculosis diagnostics; Löwenstein-Jensen medium with medicines for testing medicine susceptibility of Mycobacterium tuberculosis; Löwenstein-Jensen medium containing glycerol is used for identification of Mycobacterium tuberculosis; Ox Thrombin for in-vitro diagnostics and Lyophilisate; and rabbit plasma. In addition, the company provides reagents, such as horse serum, bovine serum, calf serum, trypsin, PBS fluid, hanks fluid, parker's fluid, Eagle 1959 medium, RPMI 1640 medium, and Ogawa medium, as well as pseudo cholinesterase, Ox fibrinogen, and rabbit complements. The company was founded in 1944 and is based in Lublin, Poland.